Skip to main navigation
MoonLake MoonLake
e: info@moonlaketx.com
  • About us
    • About MoonLake TX
    • Careers
    • Team
  • Science
    • The science
    • Therapeutic focus
    • Pipeline
  • Investor relations
    • Investors overview
    • Stock information
    • Press releases
    • Events & presentations
    • Corporate governance
    • Financials & filings
    • Email alerts
Site - Main
  • About us
    • About MoonLake TX
    • Careers
    • Team
  • Science
    • The science
    • Therapeutic focus
    • Pipeline
  • Investor relations
    • Investors overview
    • Stock information
    • Press releases
    • Events & presentations
    • Corporate governance
    • Financials & filings
    • Email alerts
e: info@moonlaketx.com

INVESTOR RELATIONS

IR Overview

Stock Information



Data Provided by Refinitiv. Minimum 15 minutes delayed.

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low
View Stock Information +
Latest press releases
Feb 02 2023
MoonLake Immunotherapeutics completes patient enrollment and randomization ahead of schedule in a Phase 2 trial of the Nanobody® sonelokimab in moderate-to-severe hidradenitis suppurativa
Dec 14 2022
MoonLake Immunotherapeutics screens first patient in Phase 2 study of the Nanobody® sonelokimab in active psoriatic arthritis
Nov 14 2022
MoonLake Immunotherapeutics Reports Third Quarter 2022 Financial Results and Provides Recent Business Update

View All News

View All Press Releases +
Upcoming events
Feb 14 - Feb 16 2023
SVB Securities Global Biopharma Conference
Mar 6 - Mar 8 2023
Cowen 43rd Annual Healthcare Conference
Mar 17 - Mar 21 2023
Annual Meeting of the American Academy of Dermatology (AAD) 2023

View All Events

View All Events +
Corporate presentations
Corporate presentation - January 2023

View All Presentations

View All Presentations +

IR contact details

Dr. Atif Khan,
Director of Strategic Planning and Projects

e: ir@moonlaketx.com

Site - Investor Tools
Print Page
RSS Feeds
Email Alerts
Contact IR

Contact Us

MoonLake Immunotherapeutics AG Dorfstrasse 29, 6300 Zug, Schweiz/Switzerland
e: info@moonlaketx.com
media: media@moonlaketx.com
IR: ir@moonlaketx.com
LinkedIn

Quick Links

  • Home
  • About us
  • Team
  • Science
  • Pipeline
  • Therapeutic focus
  • Investor relations
  • Careers
  • Privacy policy

© 2023 -  MoonLake Immunotherapeutics

Privacy Policy